Maturana-Ramírez A, Rojas-Zúñiga G, Cisternas CS, Aitken-Saavedra J. Curcumin in oral potentially malignant disorders and oral squamous cell carcinoma: Clinical and biological evidence from a systematic review. J Clin Exp Dent. 2026;18(9):e1076-86.
doi:10.4317/jced.64298
https://doi.org/10.4317/jced.64298
References
|
1. WHO Classification of Tumours Editorial Board. Head and neck tumours. 5th ed. Vol. 9. Lyon: International Agency for Research on Cancer; 2022. |
|
|
2. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, Lodi G, Weber Mello F, Monteiro L, Ogden GR, Sloan P, Johnson NW. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862-80. |
|
|
3. Warnakulasuriya S, Ramos-García P, González-Moles MÁ. Oral lichen planus and systemic diseases. J Dent Res. 2026;105(1):31-41. |
|
|
4. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, Di Maio P, Spriano G, Pardiñas López S, Shanti RM. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539-55. |
|
|
5. Scully C, Bagan J. Oral squamous cell carcinoma: an overview. Oral Oncol. 2009;45(4-5):301-8. |
|
|
6. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, Ruiz-Ávila I, Ramos-García P. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2021;27(4):813-28. |
|
|
7. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-8. |
|
|
8. Sathiasekar AC, Mathew DG, Lal MSJ, Prakash A, Kumar KUG. Oral field cancerization. J Pharm Bioallied Sci. 2017;9(Suppl 1):S23-5. |
|
|
9. Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, Carrassi A, MacDonald LCI, Worthington HV. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;(7):CD001829. |
|
|
10. Khosrojerdi M, Gumpricht E, Jamialahmadi T, Kesharwani P, Sahebkar A. Curcumin in oral lichen planus. Curr Med Chem. 2023;30(15):1684-8. |
|
|
11. Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H. Cancer chemopreventive activity of diversin. Phytomedicine. 2010;17(3-4):269-73. |
|
|
12. Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric and curcumin: a review of therapeutic and biological activities. Phytother Res. 2018;32(6):985-95. |
|
|
13. Ahmad T, Khan I, Sultana A, Rizvi M, Moshahid A. A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia: a randomized clinical trial. Natl J Maxillofac Surg. 2023;14(3):413-9. |
|
|
14. Kuriakose MA, Ramdas K, Dey B, Iyer S, Rajan G, Elango KK, Suresh A, Ravindran D, Kumar RR, Prathiba R, Ramachandran S, Asok Kumar N, Thomas G, Somanathan T, Ravindran HK, Ranganathan K, Katakam SB, Parashuram S, Jayaprakash V, Pillai MR. A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia. Cancer Prev Res (Phila). 2016;9(8):683-91. |
|
|
15. Khare P, Devra AG, Patidar M, Punga R, Gupta N, Sohn SY. Curcumin lozenges in leukoplakia. J Oral Maxillofac Pathol. 2024;28(4):626-32. |
|
|
16. Deb S, Bhargava D, Bansal P, Kanuru V. Role of nano curcumin on superoxide dismutase levels in leukoplakia. J Oral Maxillofac Pathol. 2022;26(1):21-5. |
|
|
17. Kia SJ, Basirat M, Mortezaie T, Moosavi MS. Oral nano-curcumin versus prednisolone in oral lichen planus. BMC Complement Med Ther. 2020;20(1):328. |
|
|
18. Amirchaghmaghi M, Pakfetrat A, Delavarian Z, Ghalavani H, Ghazi A. Evaluation of the efficacy of curcumin in the treatment of oral lichen planus: a randomized controlled trial. J Clin Diagn Res. 2016;10(5):ZC134-7. |
|
|
19. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S Jr. High-dose curcuminoids are efficacious in reducing symptoms and signs of oral lichen planus. J Am Acad Dermatol. 2012;66(5):752-60. |
|
|
20. Chainani-Wu N, Collins K, Silverman S Jr. Use of curcuminoids in a cohort of patients with oral lichen planus. Phytomedicine. 2012;19(5):418-23. |
|
|
21. Kia SJ, Shirazian S, Mansourian A, Khodadadi Fard L, Ashnagar S. Comparative efficacy of topical curcumin and triamcinolone. J Dent (Tehran). 2015;12(11):789-96. |
|
|
22. Nosratzehi T, Arbabi-Kalati F, Hamishehkar H, Bagheri S. Curcumin mucoadhesive paste in oral lichen planus. J Natl Med Assoc. 2018;110(1):92-7. |
|
|
23. Khaitan T, Vishal, Kabiraj A, Sinha DK, Ranjan R, Singh R. Curcuma longa in the treatment of symptomatic oral lichen planus. Indian J Dermatol. 2022;67(4):478. |
|
|
24. Srivastava R, Sarkar S, Gupta P, Pradhan D, Bagde H, Dhopte A. Ayurvedic gel in erosive oral lichen planus. J Pharm Bioallied Sci. 2024;16(Suppl 1):S868-70. |
|
|
25. Thomas AE, Varma B, Kurup S, Jose R, Chandy ML, Kumar SP, Aravind MS, Ramadas AA. Evaluation of efficacy of 1% curcuminoids as local application in management of oral lichen planus: interventional study. J Clin Diagn Res. 2017;11(4):ZC89-93. |
|
|
26. Shivu ME, Gupta N, Mulla M, Mulla M, Bajoria AA, Varshney A. Evaluation of turmeric, ashwagandha, and aloe vera in the management of oral lichen planus lesion. J Pharm Bioallied Sci. 2024;16(Suppl 3):S2043-5. |
|
|
27. Neetha MC, Panchaksharappa MG, Pattabhiramasastry S, Shivaprasad NV, Venkatesh UG. Synergism between green tea extract and curcumin. J Contemp Dent Pract. 2020;21(5):521-31. |
|
|
28. Rai B, Kaur J, Jacobs R, Singh J. Mechanism of curcumin in pre-cancerous lesions. J Oral Sci. 2010;52(2):251-6. |
|
|
29. Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, Dong TS, Eklund M, Russ E, Nasser H, Lagishetty V, Guo R, Sajed D, Mudgal S, Mehta P, Avila L, Srivastava M, Faull K, Jacobs J, Pellegrini M, Shin DS, Srivatsan ES, Wang MB. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes. Cancer. 2020;126(8):1668-82. |
|
|
30. Latimer B, Ekshyyan O, Nathan N, Moore-Medlin T, Rong X, Ma X, Khandelwal A, Christy HT, Abreo F, McClure G, Vanchiere JA, Caldito G, Dugas T, McMartin K, Lian T, Mehta V, Nathan CAO. Enhanced systemic bioavailability of curcumin through transmucosal administration of a novel microgranular formulation. Anticancer Res. 2015;35(12):6411-8. |
|
|
31. Sridharan G. Areca nut and tobacco chewing and oral cancer: a review. Indian J Med Paediatr Oncol. 2024;45(1):5-12. |
|
|
32. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16(6):4567-98. |
|
|
33. Salehi B, Stojanović-Radić Z, Matejić J, Sharifi-Rad M, Kumar NVA, Martins N, Sharifi-Rad J. The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem. 2019;163:527-45. |
|
|
34. Farah CS. Molecular, genomic and mutational landscape of oral leukoplakia. Oral Dis. 2021;27(4):803-12. |
|
|
35. Foy JP, Bertolus C, William WN Jr, Saintigny P. Immunological and classical subtypes of oral premalignant lesions. Oncoimmunology. 2018;7(10):e1496880. |
|
|
36. Kurago ZB. Etiology and pathogenesis of oral lichen planus: an overview. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):72-80. |
|
|
37. Khamis A, Salzer L, Schiegnitz E, Stauber RH, Gül D. Vitamin D and oral potentially malignant disorders. Int J Mol Sci. 2023;24(20):15058. |
|
|
38. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. |
|